Reunion Neuroscience, Inc. operates drug discovery and development business. Its novel psychedelic drug development, committed to innovating therapeutic solutions for mental health conditions by developing proprietary serotonin receptor agonist compounds. The company was founded on October 1, 2020 and is headquartered in Toronto, Canada.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Field Trip Health Ltd.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Field Trip Health Ltd. market cap is $13.12M.
What is the 52-week high for Field Trip Health Ltd.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Field Trip Health Ltd. 52 week high is $22.00 as of September 07, 2025.
What is the 52-week low for Field Trip Health Ltd.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Field Trip Health Ltd. 52 week low is $0.6303 as of September 07, 2025.
What is Field Trip Health Ltd. stock price today?
Field Trip Health Ltd. stock price today is $1.13.
What was Field Trip Health Ltd. stock price yesterday?
Field Trip Health Ltd. stock price yesterday was $1.13.
What is the PE ratio of Field Trip Health Ltd.?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Field Trip Health Ltd.’s P/E ratio is -0.35.
What is the Price-to-Book ratio of Field Trip Health Ltd.?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Field Trip Health Ltd. P/B ratio is 0.8340.
What is Field Trip Health Ltd.'s EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Field Trip Health Ltd.'s EBITDA is 0.64.
What is the 50-day moving average of Field Trip Health Ltd.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Field Trip Health Ltd. 50-day moving average is $1.04.
